Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. 1995

Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
Second Department of Internal Medicine, Ehime University School of Medicine, Japan.

OBJECTIVE To elucidate an association between left ventricular geometric adaptation to sustained hypertension and preclinical extracardiac target organ damage in essential hypertension. We also studied the clinical significance of neurohumoral factors for cardiovascular structural changes. METHODS One hundred and forty patients with essential hypertension were divided into four subgroups, based on left ventricular mass index and relative wall thickness. With respect to extracardiac target organ damage, we measured the funduscopic grade of retinal changes and serum creatinine levels. RESULTS Among the hypertensive patients, only 19 (14%) had a typical concentric hypertrophy (increase in left ventricular mass index and relative wall thickness). Hypertensive patients with concentric hypertrophy had the most advanced funduscopic abnormalities and the greatest renal involvement, and hypertensive patients without left ventricular hypertrophy had the least extracardiac target organ damage. Plasma renin activity and plasma aldosterone concentration were higher in hypertensive patients with than in those without concentric hypertrophy. In a multiple regression model there was a strongly significant correlation between the degree of left ventricular mass index and the severity of hypertensive retinopathy and renal involvement, independent of office blood pressure. CONCLUSIONS These results clearly demonstrate that echocardiographically determined left ventricular mass and geometry stratify extracardiac target organ damage in patients with essential hypertension more closely than office blood pressure. The present study also suggests that, in addition to blood pressure load, the renin-angiotensin-aldosterone system appears to play an important role in myocardial hypertrophy and peripheral vascular damage in hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females

Related Publications

Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
June 2002, Journal of human hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
July 2000, Hypertension research : official journal of the Japanese Society of Hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
August 1988, The American journal of cardiology,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
June 1998, American journal of hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
June 2010, Journal of human hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
August 2000, American journal of hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
March 2018, Journal of hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
April 2014, Journal of human hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
July 2019, American journal of hypertension,
Y Shigematsu, and M Hamada, and M Mukai, and H Matsuoka, and T Sumimoto, and K Hiwada
December 2001, Journal of hypertension,
Copied contents to your clipboard!